143 studies found for:    KL
Show Display Options
Rank Status Study
1 Recruiting Phase 2 Study to Evaluation the Safety and Efficacy of Orally Administered KL7016 in Patients With Dry Eye Syndrome
Condition: Dry Eye Syndrome
Interventions: Drug: KL7016 900mg;   Drug: KL7016 600mg;   Drug: Placebo
2 Completed The Role of KL-6 in the Clinical Diagnosis of ILD
Condition: Interstitial Lung Disease
Intervention:
3 Completed Clinical Image Evaluation for the DREX-KL80 Imaging System
Condition: Obtain Diagnostic Images With the New Digital Camera and Image Processor for Evaluation.
Intervention: Device: Radiography and Fluoroscopy Imaging System
4 Active, not recruiting Impact of Volunteer Peer-Led Intervention for Weight Control in Primary Care
Condition: Weight Loss
Intervention: Behavioral: Weight loss Groups
5 Completed
Has Results
Lucinactant for Treatment of Acute Hypoxemic Respiratory Failure in Children up to Two Years Old
Condition: Acute Hypoxemic Respiratory Failure
Interventions: Drug: Lucinactant;   Other: Sham Comparator
6 Terminated
Has Results
KL₄Surfactant Treatment in Patients With ARDS
Condition: Acute Respiratory Distress Syndrome
Interventions: Drug: Lucinactant;   Other: Standard of Care
7 Completed Interleukin-2 and Stem Cell Factor in Treating Patients With AIDS or AIDS-Related Cancer
Condition: Lymphoma
Interventions: Biological: aldesleukin;   Biological: recombinant human stem cell factor
8 Not yet recruiting KL-6 Protein as a Biomarker of Lung Injury in Viral Bronchiolitis
Condition: Acute Viral Bronchiolitis
Intervention:
9 Terminated Klotho Gene Polymorphism in Dialyzed Patients With Hyperphosphatemia
Conditions: Chronic Kidney Disease;   End Stage Renal Disease;   Hyperphosphatemia;   Renal Osteodystrophy
Intervention:
10 Completed Stem Cell Factor Medication for Aplastic Anemia
Conditions: Aplastic Anemia;   Pancytopenia
Intervention: Drug: Recombinant Methionyl Human Stem Cell Factor (r-metHuSCF)
11 Completed A Phase I/II Trial of Recombinant-Methionyl Human Stem Cell Factor (SCF) in Adult Patients With Sickling Disorders
Conditions: Hemoglobin SC Disease;   Sickle Cell Anemia
Intervention: Drug: Recombinant-methionyl human stem cell factor
12 Unknown  The Role Of FGF23, Klotho, And Sclerostin In Kidney Stone Formers
Condition: Kidney Stones
Intervention: Other: no intervention
13 Terminated Biological Therapies Following Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Advanced Breast Cancer
Conditions: Breast Cancer;   Lymphoma
Interventions: Drug: aldesleukin;   Drug: filgrastim;   Drug: recombinant human stem cell factor;   Procedure: peripheral blood stem cell transplantation
14 Unknown  Factors Related to the Progression of Chronic Kidney Disease
Condition: Chronic Kidney Disease
Intervention:
15 Active, not recruiting Lenalidomide and Recombinant Human Stem Cell Factor for Treatment of Myelodysplasia
Condition: Myelodysplasia
Intervention: Drug: Lenalidomide + Ancestim
16 Completed Arnogene: A Phosphocalcic Study in Dialysis
Condition: Dialysis
Intervention: Genetic: blood sample
17 Suspended Stem Cell Factor (SCF) Priming of Haematopoietic Stem Cell Grafts in Malignant Lymphoma
Condition: Malignant Lymphoma
Interventions: Drug: r-metHuSCF and Filgrastim;   Drug: Chemotherapy plus Filgrastim
18 Terminated
Has Results
Feasibility Study of Aerosolized Surfaxin in the Prevention of Respiratory Distress Syndrome (RDS) in Premature Infants
Condition: Respiratory Distress Syndrome
Intervention: Drug: Aerosolized lucinactant
19 Terminated
Has Results
Phase III Randomized Study of Lucinactant in Full Term Newborn Infants With Meconium Aspiration Syndrome
Condition: Meconium Aspiration
Interventions: Drug: Lucinactant;   Other: Standard Care
20 Completed
Has Results
Effect of Lucinactant on Mucus Clearance in Cystic Fibrosis Lung Disease
Condition: Cystic Fibrosis
Interventions: Drug: Lucinactant first;   Drug: Placebo first

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years